# PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

> **NCT04199741** · PHASE1,PHASE2 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 53 (estimated)

## Conditions studied

- Small Cell Lung Cancer
- Small Cell Lung Carcinoma

## Interventions

- **DRUG:** 89Zr-DFO-SC16.56
- **DRUG:** SC16.56, Phase I, Cohort 2
- **DRUG:** SC16.56, Phase I, Cohort 3
- **DRUG:** SC16.56, Phase II

## Key facts

- **NCT ID:** NCT04199741
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-12-11
- **Primary completion:** 2026-06-11
- **Final completion:** 2026-06-11
- **Target enrollment:** 53 (ESTIMATED)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04199741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04199741, "PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04199741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*